{
  "pmcid": "8183183",
  "sha256": "d8aa4c667950c47f795e9168220609d2f940279197e1a7a7703c616a13c89e33",
  "timestamp_utc": "2025-11-09T16:17:08.729927+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.034419243986253,
    "reading_ease": 50.504824742268056,
    "word_count": 291
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Background: Local excision (LE) after chemoradiotherapy is a new option in low rectal cancer, but morbidity has never been compared prospectively with total mesorectal excision (TME)."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Method: This was a post-hoc analysis from a randomized trial."
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with clinical T2/T3 low rectal cancer with good response to the chemoradiotherapy and having either LE, LE with eventual completion TME, or TME were considered."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Early and late morbidity were compared in patients treated either by LE or TME after neoadjuvant chemoradiotherapy for rectal cancer."
      },
      "Objective": {
        "score": 1,
        "evidence": "Early and late morbidity were compared in patients treated either by LE or TME after neoadjuvant chemoradiotherapy for rectal cancer."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Early (1 month) and late (2 years) morbidities were compared between the three groups."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Method: This was a post-hoc analysis from a randomized trial."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Early surgical morbidity (20 per cent LE versus 36 per cent TME versus 43 per cent completion TME, P = 0.025) and late surgical morbidity (4 per cent versus 33 per cent versus 57 per cent, P < 0.001) were significantly lower in the LE group than in the TME or the completion TME group."
      },
      "Harms": {
        "score": 1,
        "evidence": "There were no deaths following surgery in any of the three groups."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}